- Medical Malpractice
- Product
- Unsafe Drugs
- Pradaxa
- Metal-on-Metal Hip Implant Litigation
- Hip Implants - DePuy ASR Hip Recall
- Hip Implants - Zimmer Durom Cup Hip Recall
- Vaginal Mesh Litigation
- Vaginal Mesh - Bard Avaulta Surgical Mesh
- Accutane
- Actos
- Avandia
- Bisphosphonate Litigation
- Chantix
- Darvon and Darvocet Recall
- Knee Implant - Zimmer NexGen CR-Flex
- Kugel Hernia Mesh Patches
- Mentor ObTape Vaginal Sling
- Ortho Evra Birth Control Patch
- Yasmin, Yaz, and Ocella Birth Control
- Other/Archive Drug Products
- Personal Injuries
- Auto Accidents
- Nursing Home Abuse
Home :: News ::Federal Medtronic Sprint Fidelis Lead Cases Dismissed with Prejudice on Grounds of Federal Preemption
Federal Medtronic Sprint Fidelis Lead Cases Dismissed with Prejudice on Grounds of Federal Preemption
All Medtronic Sprint Fidelis defibrillator lead lawsuits pending across the country were previously consolidated before Judge Richard H. Kyle of the U.S. District Court for the District of Minnesota. Early on in this litigation, Medtronic filed a motion to dismiss these lawsuits on the basis that federal regulatory preemption blocked the filing of these types of cases in state court against the company since the FDA had already approved the Medtronic lead device under federal regulations. Unfortunately, on January 5, 2009, Judge Kyle issued a ruling in favor of Medtronic whereby all individual lawsuits pending against Medtronic were dismissed with prejudice.